MedTrace Logo

Comparison of Holmium Laser and Thulium Laser for Mini PCNL

NCT06266793 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-05-23

No results posted yet for this study

Summary

This is a single institution, single surgeon, randomized controlled trial to evaluate the Boston Scientific Lumenis Pulse 120H Moses 2.0 holmium laser versus the Olympus Soltive Superpulsed thulium fiber laser (TFL) for medium-to-large stones in the mini PCNL setting.

Conditions

  • Nephrolithiasis
  • Percutaneous Nephrolithotomy

Interventions

DEVICE

Holmium Laser

Assigned to be treated using the Lumenis Pulse 120H Moses 2.0 Holmium Laser.

DEVICE

Thulium Laser

Assigned to be treated using the Olympus Soltive Thulium SuperPulsed Fiber Laser

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • MaineHealth

    lead OTHER

Principal Investigators

  • David W Sobel, MD · MaineHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-07
Primary Completion
2027-06-01
Completion
2027-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06266793 on ClinicalTrials.gov